Multidetector Computed Tomography to Facilitate Transcatheter Aortic Valve Implantation

被引:0
作者
Leipsic J. [1 ,2 ]
Wood D.A. [2 ]
Gurvitch R. [2 ]
Hague C.J. [1 ]
机构
[1] Department of Radiology, St. Paul's Hospital, University of British Columbia, Vancouver
[2] Division of Cardiology, Department of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, BC, V6S 1Y6
关键词
Multidetector computed tomography; Transcatheter aortic valve replacement;
D O I
10.1007/s12410-011-9106-4
中图分类号
学科分类号
摘要
Minimally invasive balloon expandable transcatheter aortic valve replacement (TAVR) is currently the standard of care for patients with inoperable severe symptomatic aortic stenosis and is an acceptable alternative to traditional aortic valve replacement in selected high-risk operable patients. Multidetector computed tomography (MDCT) is an integral component of diagnostic workup prior to TAVR. We review the pivotal role of MDCT in patient selection by discussing pre-procedural assessment of iliofemoral, aortic root, and annular geometry. We summarize how MDCT can help guide percutaneous vascular access as well as accurately determine the correct co-axial valve plane and transcatheter valve size. Finally, we discuss how MDCT provides important information about long-term valve durability by assessing valve eccentricity, leaflet and stent integrity, valve recoil, and valve migration. © 2011 Springer Science+Business Media, LLC.
引用
收藏
页码:457 / 467
页数:10
相关论文
共 35 条
[1]  
Nkomo V.R., Gardin J.M., Skelton T.N., Et al., Burden of valvular heart diseases, Lancet, 368, pp. 1005-1011, (2006)
[2]  
Bonow R.O., Carabello B.A., Kanu C., Et al., ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed, J Am Coll Cardiol, 48, (2006)
[3]  
Iung B., Baron G., Butchart E.G., Et al., Prospective survey of patients with valvular heart disease in Europe, Eur Heart J, 24, pp. 1231-1243, (2003)
[4]  
Svensson L.G., Dewey T., Kapadia S., Et al., United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex, Ann Thorac Surg, 86, pp. 46-55, (2008)
[5]  
Walther T., Falk V., Kempfert J., Et al., Transapical minimally invasive aortic valve implantation
[6]  
the initial 50 patients, Eur J Cardiothorac Surg, 33, pp. 983-988, (2008)
[7]  
Grube E., Schuler G., Buellesfeld L., Et al., Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome, J Am Coll Cardiol, 50, pp. 69-76, (2007)
[8]  
Webb J.G., Pasupati S., Humphries K., Et al., Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis, Circulation, 116, pp. 755-763, (2007)
[9]  
Walther T., Simon P., Dewey T., Et al., Transapical minimally invasive aortic valve implantation: multicenter experience, Circulation, 116, (2007)
[10]  
Leon M.B., Smith C.R., Mack M., Et al., Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery, N Engl J Med, 363, 17, pp. 1597-1607, (2010)